PCK2 and Insulin resistance: In animal models, it has been recently reported that mice with chronic hyperresistinemia have elevated glucose production due to the increased expression of hepatic phosphoenolpyruvate carboxykinase (PEPCK) and hepatic insulin resistance [9].